Intervention Review

Antifibrinolytic therapy to reduce haemoptysis from any cause

  1. Gabriela Prutsky1,2,
  2. Juan Pablo Domecq1,2,*,
  3. Carlos A Salazar3,
  4. Roberto Accinelli4

Editorial Group: Cochrane Tobacco Addiction Group

Published Online: 18 APR 2012

Assessed as up-to-date: 27 DEC 2010

DOI: 10.1002/14651858.CD008711.pub2


How to Cite

Prutsky G, Domecq JP, Salazar CA, Accinelli R. Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD008711. DOI: 10.1002/14651858.CD008711.pub2.

Author Information

  1. 1

    Mayo Clinic, Knowledge and Evaluation Research Unit, Rochester, Minnesota, USA

  2. 2

    CONEVID, Unidad de conocimiento y evidencia, Cayetano Heredia Peruvian University, Lima, Peru

  3. 3

    Universidad Peruana Cayetano Heredia, Department of Medicine, Lima, Peru

  4. 4

    Departamento de Medicina, Universidad Peruana Cayetano Heredia and Hospital Nacional Cayetano Heredia, Laboratorio de Respiración of the Instituto de Investigaciones de la Altura, Lima, Peru

*Juan Pablo Domecq, CONEVID, Unidad de conocimiento y evidencia, Cayetano Heredia Peruvian University, Lima, Peru. jpdomecqg@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 18 APR 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Christian Arvei Moen, Amy Burrell, Joel Dunning, Does tranexamic acid stop haemoptysis?: Table 1:, Interactive CardioVascular and Thoracic Surgery, 2013, 17, 6, 991

    CrossRef